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The p75 neurotrophin (NT) receptor (p75NTR) plays a crucial role in
balancing survival-versus-death decisions in the nervous system. Yet,
despite 2 decades of structural and biochemical studies, a comprehen-
sive, accepted model for p75NTR activation by NT ligands is still missing.
Here, we present a single-molecule study of membrane p75NTR in living
cells, demonstrating that the vast majority of receptors are monomers
before and after NT activation. Interestingly, the stoichiometry and
diffusion properties of the wild-type (wt) p75NTR are almost identical
to those of a receptor mutant lacking residues previously believed to
induce oligomerization. The wt p75NTR andmutated (mut) p75NTR differ
in their partitioning in cholesterol-rich membrane regions upon nerve
growth factor (NGF) stimulation: We argue that this is the origin of the
ability of wt p75NTR , but not of mut p75NTR, to mediate immature NT
(proNT)-induced apoptosis. Both p75NTR forms support proNT-induced
growth cone retraction: We show that receptor surface accumulation is
the driving force for cone collapse. Overall, our data unveil the multi-
faceted activity of the p75NTR monomer and let us provide a coherent
interpretative frame of existing conflicting data in the literature.
p75 neurotrophin receptor | membrane oligomeric state | single-molecule
microscopy | apoptosis | growth cone collapse
The p75 neurotrophin (NT) receptor (p75
NTR) is a single-pass
transmembrane (TM) receptor of the tumor necrosis factor
(TNF) receptor superfamily (1). Along with the Trk tyrosine
kinase receptor (2) and the Vps10p domain-sorting receptor fami-
lies (3), p75NTR binds and is activated by NTs, small secreted
homodimeric growth factors. NTs regulate survival, differentia-
tion, and specification in developing neurons and plasticity and
maintenance in adult neurons (4). This paradigmatic signaling
system finely orchestrates 2 opposite pathways—survival versus
death—in the central and peripheral nervous systems, and its
alterations have a causal role in neurodegeneration (5, 6). No-
tably, p75NTR is the only NT receptor with significant binding
affinity for all NTs, as well as for their respective immature forms
(proNTs) (1), thus playing a central role in their balance. The
p75NTR has long been considered a pan-NT coreceptor of Trk
receptors, cooperating in the formation of high-affinity binding
sites for NTs (7). However, the predicted ternary complex be-
tween NTs, Trk (or sorting receptors), and p75NTR has never
been observed with structural biology techniques, and the
available crystal structures of the nerve growth factor (NGF)-
TrkA (8) [and NGF-SorC2 (9)], NT–p75NTR binary complexes
have opposite orientations: This casts doubts on how a ternary
complex could assemble (10). Available NT-p75NTR structures
are conflicting per se, as the NGF-p75NTR cocrystal has 2:1 stoichiom-
etry (11), while the NT3-p75NTR cocrystal has 2:2 stoichiometry (12),
with no obvious rationale for their difference. In addition,
p75NTR binds a number of ligands unrelated to NTs and has in-
dependent functions from Trks in controlling neurite outgrowth
and morphology (13, 14), cell cycle withdrawal of developing neural
progenitors (15), and viral-related neuropathies (16). It is thus clear
that the structural basis of p75NTR signaling still needs proper un-
derstanding. On the basis of Western blot analysis from cell lysates,
it was proposed that p75NTR acts as a preformed disulfide-linked
dimer via a conserved TM cysteine residue (Cys256 in human
numbering, employed throughout this paper, corresponding to res-
idues 257 in rat and 259 in mouse numberings), which would act as a
fulcrum to propagate a conformational change from the p75NTR
extra- to intracellular domain upon NT binding (17). Cys256 muta-
tion abolished NT-dependent apoptotic activity in cultured neurons
and in a knock-in mouse model (18); however, this model was re-
cently challenged by the report that this propagation of conforma-
tional changes could not be supported by the flexible p75NTR
juxtamembrane (JM) intracellular region (19). Furthermore, a sim-
ilar Western blot analysis performed by Anastasia et al. (20) showed
the existence of p75NTR trimers, which are more represented than
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dimers; oligomerization, however, was not necessary for proNGF-
induced growth cone collapse in developing neurons (20).
Here, we directly and quantitatively assess p75NTR oligomer-
ization status in the plasma membrane of living cells by means of
single-molecule fluorescence microscopy with a minimally invasive
strategy (21, 22); this relies on insertion of a short peptide tag
in the p75NTR protein and its labeling with 1:1 stoichiometry (23,
24). This method also allows imaging the receptor with small or-
ganic dyes, which, unlike the more cumbersome Quantum dots
(Qdot), permits one to retrieve the receptor oligomeric state from
their fluorescent intensity (21). We show that membrane p75NTR
is mostly a fast-diffusing monomer, regardless of NT stimulation.
Its self-interactions are far too transient to result in substantial
receptor di- or trimerization; importantly, they do not depend on
Cys256 or on other residues previously suggested to play a role
in receptor oligomerization. We also gather evidence on why
the p75NTR C256A mutant does not elicit NT-dependent apo-
ptosis (18) but is functional for growth cone collapse signal-
ing (20). By solving this apparent contradiction, we revisit
here p75NTR function, in the conceptual framework of a versatile
monomeric receptor.
Results
Expression, Validation, and Membrane Fluorolabeling of Human
p75NTR Constructs. We previously demonstrated that p75NTR can
be enzymatically labeled with small chemical probes (e.g., biotin,
organic fluorophores) in a site-specific way, inserting 12 amino
acid-long tags of the ACP/PCP family at its N terminus (23). This
allows a covalent modification with 1:1 stoichiometry (i.e.,
1 probe per p75NTR molecule) of the receptors exposed on the
surface of living cells (24, 25). Here, we used S6-p75NTR (Fig.
1A) for its better labeling performance when compared with
A1-p75NTR (SI Appendix, Fig. S1). We found that S6-p75NTR
correctly localizes on the plasma membrane, as well as on intracellular
structures like the nuclear envelope, similar to endogenous p75NTR
expressed by PC12 cells (26) (Fig. 1B). Like endogenous p75NTR
(SI Appendix, Fig. S2), S6-p75NTR undergoes palmitoylation (Fig. 1C),
an important posttranslational modification for p75NTR death
domain signaling capability (27). The p75NTR was recently repor-
ted to localize asymmetrically in neurons, helping in specifying the
future axon (28); accordingly, biotinylated S6-p75NTR receptors
preferentially localize in neurites and growth cones in devel-
oping hippocampal neurons (Fig. 1D). Furthermore, S6-p75NTR–
EGFP was able to induce growth cone collapse in the same
neurons upon proNGF administration (Fig. 1E), as reported for pre-
vious p75NTR constructs devoid of chemical tags (29). Finally,
proBDNF binding to p75NTR was recently reported to increase
the number of apoptotic neurons (18) (Fig. 1F, Top). By transducing
S6-p75NTR in cortical neurons from p75NTR knockout (KO) mice
(30) with an inducible lentiviral vector (24), we found that it was able
to recapitulate proBDNF-induced apoptosis (Fig. 1F, Middle and
Bottom). The lower percentage of apoptotic neurons, with respect to
that raised by endogenous p75NTR, is likely due to the presence of
untransduced neurons.
Overall, our data demonstrate that the S6-tagged construct of
human p75NTR retains the properties of endogenous p75NTR. We
therefore employed it to visualize the p75NTR membrane pool in
living cells and to describe its behavior in a direct, unperturbed
physiological way.
p75NTR Single Molecules Diffuse as Monomers in the Cell Membrane.
We first sought to investigate the membrane p75NTR diffusive
properties and oligomerization state in living cells. To this end,
we expressed S6-p75NTR in neuroblastoma SK-N-BE(2) cells, a
line that conceivably models a neuronal membrane with the
advantage of lacking endogenous p75NTR and TrkA at both
messenger RNA and protein levels (31). Once labeled with
Abberior635P dye (SI Appendix, Fig. S3), S6-p75NTR imaged
with total internal reflection fluorescence (TIRF) microscopy
appears as a carpet of spots decorating the cell basal membrane,
A
B
F
C
D
E
untreated
nt
Fig. 1. Expression, validation, and membrane fluorolabeling of human
p75NTR constructs. (A) Scheme of the S6-p75NTR construct. The S6 tag is inserted
between the signal peptide (SP) and cysteine-rich domains 1 to 4 (CRD1-4). CD,
chopper; DD, death domain. (B) S6-p75NTR–EGFP (green) localizes in the plasma
membrane and, to a minor extent, on the nuclear membrane in SHSY5Y cells
(Left) as endogenous p75NTR (green, Top Right ) in PC12 cells expressing far-
nesyl (farn)-GFP or lamin-RFP (both red, Right). (Bottom Right) Intensity (I) vs.
distance (d) plot along yellow dashed lines. (Scale bar, 10 μm.) (C) S6-p75NTR is
palmitoylated. (Top) Scheme of the hydroxylamine (HA)-catalyzed palmitoyl/
biotin exchange. (Bottom) Western blot showing the streptavidin pulldown
(Pd) and the corresponding nonpalmitoylated/biotinylated supernatant (Spn);
the control reaction without HA is also shown. WCE, whole cell extract. (D) S6-
p75NTR is polarized in developing hippocampal neurons. The maximum in-
tensity projection of a TIRF movie of Qdot-labeled S6-p75NTR (white) and the
area explored by S6-p75NTR (blue) superimposed on the cell mask (gray) are
shown. DIC, differential interference contrast. (Scale bars, 5 μm.) The graph
shows the relative enrichment in the explored area in somas and neurites.
***P < 0.001, paired Student’s t test (2-tailed). Bars are mean ± SEM. The
dotted red line is the value expected for a nonpolarized localization. (E, Left)
Confocal images of growth cones of hippocampal neurons transfected with
TagRFP-actin only (red, Top) or with S6-p75NTR (green) and TagRFP-actin
(Bottom), untreated or after 30 min of incubation with 20 ng/mL proNGF.
(Scale bars, 5 μm.) (E, Right) Quantification of the growth cone area is reported
in the graph. Bars are mean ± SEM. ***P < 0.001, 1-way ANOVA (Bonferroni
multiple comparisons). nt, nontransfected. (F, Top) Cleaved-caspase-3 (red)/
MAP2 (green) immunofluorescence images to quantify proBDNF-induced ap-
optosis in cortical neurons from wt and p75 KO mice (DAPI is shown in blue).
(Scale bar, 20 μm.) (F, Bottom) Percentage of cleaved caspase-3–positive neu-
rons is reported as mean ± SEM in the graph. ***P < 0.001, unpaired Student’s
t test (2-tailed); ###P < 0.001, 1-way ANOVA (Tukey’s multiple comparisons). ns,
not significant at the 0.05 level. nt, nontransduced.
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each corresponding to a single receptor particle (Fig. 2 A and B).
With a Tet-On inducible promoter (24), we tuned receptor ex-
pression from low (∼0.1 spot per square micrometer) to the
highest density allowing us to track p75NTR receptors individually
(∼0.5 spot per square micrometer), and even to bulk p75NTR
expression (Fig. 2A). Receptors at densities from 0.1 to 0.45 spot
per square micrometer were followed over time (Movies S1 and
S2), and tracked at the single-particle level (32) (Fig. 2B and Movie
S3). We compared wild-type p75NTR (wt p75NTR; Fig. 2C) with
2 reference monomeric or dimeric variants of S6-tagged p75NTR.
The “monomeric” form contains C256A and G265I mutations on
the p75NTR TM domain, which were reported to inhibit covalent
and noncovalent receptor dimerization, respectively (17), along with
a deletion in its JM region that inhibits intracellular clustering (33)
(mutant p75NTR [mut p75NTR]; Fig. 2C). The mut p75NTR re-
capitulated the localization observed for wt p75NTR (SI Appendix,
Fig. S4 A and B); importantly, it did not display the high-molecular-
weight bands in Western blots (SI Appendix, Fig. S4C) previously
identified as putative receptor oligomeric forms (17, 20). To force
dimerization, we replaced the entire wt p75NTR extracellular JM
region with the c-jun leucine-zipper domain, as in a study by Brooks
et al. (34) (dim p75NTR; Fig. 2C).
In SK-N-BE(2) cells, analysis of the short-time diffusion co-
efficient (D) distributions, as in studies by Marchetti et al. (21)
and Callegari et al. (25), revealed that wt p75NTR and mut
p75NTR are indistinguishable, while dim p75NTR is significantly
slower, showing a distribution shifted toward D values compat-
ible with what is expected for dimers (35) and a somewhat higher
low-D tail (Fig. 2D); these data suggest the absence of stable
dimers for both wt p75NTR and mut p75NTR. To identify possible
transient p75NTR dimers, we analyzed the dynamic association/
dissociation of spots during their trajectories (merge and split
[M&S] events, shown in Movies S4 and S5 and schematized in Fig.
2F), as previously done by Kasai and Kusumi (36). The number of
M&S events per membrane area was significantly lower for dim
p75NTR than for wt p75NTR and mut p75NTR; the latter 2, instead,
did not differ significantly (Fig. 2E). This shows that the 3 p75NTR
constructs display an observable dynamic equilibrium between
monomers and dimers, but while wt p75NTR has association/dis-
sociation kinetics similar to mut p75NTR, dim p75NTR has either a
higher dimerization probability or a lower separation rate. We also
quantified the mean duration of transient dimerization (Td)
events (orange in Fig. 2F), i.e., the trajectory segments between
a merge event and a split event. The distribution of average Td
lifetime demonstrated that while wt p75NTR and mut p75NTR
display dimerization events equally peaked between 0.4 and 0.5 s,
those of dim p75NTR peak at 0.6 and 0.8 s (Fig. 2G). These results
allow us to determine that wt p75NTR does not form stable dimers
or higher oligomers in the living cell membrane.
Because of the transient nature of p75NTR dimers, as well as of
photobleaching during tracking, analysis of the average intensity
of the trajectories in live cells could not give an unambiguous
answer on the stoichiometry (SI Appendix, Fig. S5). Therefore,
we analyzed the intensity step photobleaching profile of isolated
p75NTR/Abberior635P spots in fixed cells (yellow boxes in Fig.
3A). For each spot, we quantified 1) the number of photo-
bleaching steps (red arrows in Fig. 3B) and 2) the mean intensity
before bleaching (IPRE; green lines in Fig. 3B). Both constitute a
direct measure of the number of molecules in a spot for receptor
membrane oligomerization (37). The vast majority of analyzed
wt p75NTR and mut p75NTR spots are monomers; that is, they
display 1 photobleaching step (about 77% for both species; Fig.
3C). Conversely, the NGF-stimulated S6-TrkA construct dis-
played a significantly higher proportion of dimers and oligo-
mers (26) (SI Appendix, Fig. S6A). Importantly, the majority of
dim p75NTR spots showed a 2-step photobleaching profile (55%;
Fig. 3C), and monomers were reduced to 35%. Only dim p75NTR
displayed a sizeable amount of spots with 3 and 4 photobleaching
steps. IPRE distributions obtained for the 3 p75
NTR variants con-
firmed the bleaching step analysis (SI Appendix, Fig. S6B).
We underline that some mut p75NTR apparent dimers were
detected (about 20% of the analyzed spots) similar to wt p75NTR:
This proves the lack of a relationship with the TM residues
previously indicated as driving receptor dimerization (17). Overall,
B
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Fig. 2. Membrane dynamics of p75NTR molecules in the cell membrane. (A)
Expression of S6-p75NTR regulated by doxycycline (doxy). TIRF images of
Abberior635P-labeled p75NTR receptors in SK-N-BE(2) cells show the de-
pendence of the number of receptors per area (blue scale) on doxycycline
concentration in the medium (black values below). (Scale bar, 5 μm.) (B) TIRF
image of S6-p75NTR labeled with Abberior635P; superimposed trajectories
are shown in blue. (Scale bar, 5 μm.) (C) S6-tagged constructs. The wt p75NTR
is as in Fig. 1A; mut p75NTR bears mutations C256A and G256I, and lacks
residues 221 to 246 encompassing the O-stalk domain in the JM region; and
dim p75NTR has residues 213 to 251 of the JM portion replaced with the
leucine zipper domain (LeuZIP) from c-jun. CD, chopper; DD, death domain;
SP, signal peptide. (D) Distribution of D for wt p75NTR (gray), mut p75NTR
(black), and dim p75NTR (blue). (E) Number of M&S events in 500-frame
movies, normalized per membrane area, for wt p75NTR (gray), mut p75NTR
(black), and dim p75NTR (blue). Boxes represent SE, lines represent median,
and whiskers represent SD. ***P < 0.001, Kruskal–Wallis test. (F) TIRF frame
with superimposed transient dimer trajectory, enlarged at the bottom for
visualizing the merge (M) between p1 (yellow) and p2 (red) particles, their
colocalization trajectory (orange) corresponding to a transient dimer (Td), and
their split (S) in p1′ (magenta) and p2′ (green) particles. (Scale bar, 2 μm.) (G)
Distribution of the cell-average duration of Td trajectories for wt p75NTR (gray),
mut p75NTR (black), and dim p75NTR (blue) constructs. Cells with 0.18 to
0.36 receptor per squaremicrometer range were considered for these analyses.
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our experiments distinguish between the diffusivity of monomers
and dimers, and challenge the existence of stable p75NTR dimers
in the membrane of live cells.
wt p75NTR and mut p75NTR Display Different Membrane Partitioning in
Response to NGF Stimulation. We next compared wt p75NTR and
mut p75NTR membrane diffusivity following NT stimulation, to see
if this might impact the oligomeric state of the receptor. Also, we
aimed at identifying a possible molecular basis, an alternative to
the lack of oligomerization, as the source of the impaired apo-
ptotic signaling of mut p75NTR following NT stimulation (17, 18).
We measured D values from trajectories of wt p75NTR and
mut p75NTR with or without 15 min of NGF stimulation. The
diffusivity of both constructs upon NGF treatment remained
significantly higher than that of the dim p75NTR construct (Fig.
4A). This suggests that NGF does not induce dimerization of
either construct. These data are consistent with the absence of
fluorescence resonance energy transfer (FRET) or homo-FRET
changes following NT addition in cells expressing fluorescent
p75NTR constructs (17, 38). However, NGF elicits a small but
statistically significant shift of D distributions of the 2 constructs
in opposite directions (i.e., it slightly slows down wt p75NTR,
while it speeds up mut p75NTR). Similarly, a slowing down of wt
p75NTR was observed in proNGF-treated neurons (SI Appendix,
Fig. S7). Since these changes are not compatible with gain or loss
of stable oligomerization, we reasoned that they might stem from
wt p75NTR and mut p75NTR movements across membrane areas
with different composition. In this scenario, lipid rafts may
represent the discriminating factor, as they could confine and
alter transiently the diffusivity of membrane proteins (39).
Cholesterol plays a key structural role in lipid rafts, and the as-
sociation of proteins with lipid rafts can be detected experi-
mentally by testing cholesterol-dependent, confined diffusion
(40). Consistently with this, p75NTR mobility was found to de-
pend on the cholesterol content in the plasma membrane (41),
and we measured a clear anticorrelation between its D value and
membrane cholesterol in 6 cellular models (Fig. 4B and SI Ap-
pendix, Fig. S8). The fastest p75NTR diffusivity is observed in
cortical neurons, which display the lowest membrane cholesterol
levels of our survey; SK-N-BE(2) cells have a cholesterol content
similar to neurons, thus validating the choice of this model sys-
tem to study p75NTR membrane dynamics.
A B
C
Fig. 3. p75NTR is predominantly a monomer in the cell membrane. (A) TIRF
image showing receptor spots on the surface of fixed cells (yellow squares
represent analyzed spots; analyzed cells had 0.2 to 0.5 spot per square mi-
crometer). (Scale bar, 1 μm.) (B) Typical intensity profile traces of a monomer
(Top), dimer (Middle), and trimer (Bottom) showing the parameters considered
in the calculation. IPRE (green line) is the particle average intensity before the
first bleaching step, red arrows point to single photobleaching steps, and the
gray line represents background intensity. a.u., arbitrary units. (C) Photo-
bleaching steps per trace for wt p75NTR, mut p75NTR, and dim p75NTR.
*
***
*** ***
***
***
*
***
wt neurons
SK-N-BE(2)
CHO
astrocytes
HEK
p75KO neurons
A
B
C
D
E
F
Fig. 4. Membrane cholesterol regulates p75NTR diffusivity and response to
NGF. (A) Box-plot for D values from trajectories of wt p75NTR or mut p75NTR
in SK-N-BE(2) cells in resting conditions (black) and up to 15 min after NGF
administration (gray); the distribution for dim p75NTR (blue) is also shown.
Boxes represent 25th to 75th percentiles, lines represent medians, and
dashed lines represent means. ***P < 0.001, Kruskal–Wallis test (with Dunn’s
means comparison). (B) Plot of membrane cholesterol (CHO) content (mean
intensity ± SEM of filipin III-stained cells) versus D of p75NTR single molecules
(peak ± full width at half maximum of its distribution as in SI Appendix, Fig.
S8C) in 6 different cell models. Cholesterol content is normalized to SK-N-
BE(2) cell results. The black line indicates linear fit. HEK, human embryonic
kidney 293 cells. (C) TIRF images of filipin III-stained SK-N-BE(2) cells exhib-
iting modulation of cholesterol levels (quantified as mean intensity ± SEM)
with mevastatin (meva., green) or soluble cholesterol (chol., red). *P <
0.05 and ***P < 0.001, 1-way ANOVA. (Scale bar, 10 μm.) (D) Same graph as
in A, obtained for NGF-stimulated wt and mut S6-p75NTR trajectories in SK-N-
BE(2) cells (gray), treated with mevastatin (green) and cholesterol (red).
***P < 0.001, Kruskal–Wallis test (with Dunn’s means comparison). (E)
Outline of the colocalization experiment with TIRF images of cholera toxin B
subunit (CT-B)-stained GM1 (green) and p75NTR single molecules (red). (Scale
bar, 5 μm; Inset, 1 μm.) (F) Quantification of wt/mut p75NTR and CT-B
colocalization in the absence or presence of NGF. Box-plots show median
and 25th to 75th percentiles of average p75NTR intensity inside CT-B–stained
domains (Iraft p75) over average p75
NTR intensity within the whole cell (Itotal
p75). Whiskers indicate Tukey intervals, and red circles represent individual
data. *P = 0.016, 1-way ANOVA (with Bonferroni comparison of means). ns,
not significant at the 0.05 level.
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Given that raft domains are crucial for apoptotic signaling via
p75NTR (42), we considered that differential residency of wt
p75NTR and mut p75NTR upon NT binding in these areas might
explain not only the D changes observed (Fig. 4A) but also their
different signaling abilities. To test this hypothesis, we first
monitored NGF-driven diffusivity of the 2 receptor forms fol-
lowing up- or down-regulation of membrane cholesterol in SK-
N-BE(2) cells (Fig. 4C). While increasing membrane cholesterol
slows down both receptor forms, removal of membrane choles-
terol has 2 opposite outcomes: wt p75NTR is accelerated, while
mut p75NTR slowed (Fig. 4D). Since the effect of cholesterol
depletion on lateral diffusion depends on the composition of the
membrane regions explored by the membrane receptors (43),
these data suggest that wt p75NTR and mut p75NTR partition into
different membrane areas after NGF binding. These relocaliza-
tions most probably occur in a very dynamic way, given the small
diffusivity changes involved (Fig. 4A and SI Appendix, Fig. S7).
Indeed, biochemical isolation of raft domains showed wt p75NTR
localizing in both raft and nonraft regions, in the absence and
presence of NGF (44, 45). Thus, to capture transient raft occupancy,
we imaged lipid rafts and p75NTR simultaneously, after 15 min of
NGF stimulation, by dual-color TIRF microscopy (Fig. 4E), similar
to the method used by Pinaud et al (46). Rafts were visualized by
cross-linking membrane ganglioside GM1 with a fluorescent cholera
toxin B subunit (47). NGF stimulation significantly increases the
localization of wt p75NTR in GM1 regions, but not that of mut
p75NTR (Fig. 4F).
We conclude that p75NTR translocates to lipid rafts upon NGF
binding, and mut p75NTR has a reduced residency in cholesterol-
rich membrane microdomains upon NGF binding compared with
the wt counterpart. Notably, in the absence of competing Trk re-
ceptors, both NTs and proNTs induce coherent effects on p75NTR
in terms of both membrane diffusivity (Fig. 4A and SI Appendix, Fig.
S7) and biological activity; for instance, proBDNF induces apoptosis
via p75NTR (18), but p75NTR also mediates apoptosis in retinal
neurons by NGF (48) and in sympathetic neurons by BDNF (49).
Membrane Cholesterol Regulates p75NTR Apoptotic Signaling. Fol-
lowing previous observations, we tested if membrane cholesterol
levels also affected NT-dependent apoptotic signaling via
p75NTR; here, C256 TM residue was shown to play a crucial role
(17, 18). Treating neurons with mevastatin and methyl-beta-
cyclodextrin (MβCD) strongly decreases membrane cholesterol,
as measured by filipin staining, while loading neurons with cho-
lesterol has the opposite effect (Fig. 5 A and B). The proBDNF-
induced apoptosis was abolished in cholesterol-depleted cortical
neurons from wt mice, while it was slightly increased upon cho-
lesterol overload (Fig. 5C). Cholesterol modulation was also ap-
plied to wt p75NTR and mut p75NTR (Fig. 5 D–F) transduced in
p75NTR KO mouse neurons and induced with 0.05 μg/mL doxy-
cycline, a concentration not leading to overexpression (Fig. 2A).
The p75NTR KO neurons were not responsive to proBDNF;
wt p75NTR, but not mut p75NTR, restored proapoptotic signaling
(Fig. 5D). When neurons were treated with mevastatin/MβCD, wt
p75NTR lost its ability to induce apoptosis, confirming our results
on wt neurons (Fig. 5 C and E). Conversely, cholesterol admin-
istration boosted proapoptotic signaling of wt p75NTR (Fig. 5 F
and G); surprisingly, the same treatment also conferred apoptotic
capability to mut p75NTR (Fig. 5 F and G). This was not an effect
of the combination of proBDNF and cholesterol load: Untrans-
duced neurons from p75NTR KO mice were not responsive in these
conditions (Fig. 5F).
From these results, we conclude that the inability of mut
p75NTR to induce apoptosis (18) (Fig. 5D) is due to its poorer
occupancy of cholesterol-rich membrane regions when compared
with wt p75NTR, rather than to impaired signaling of the protein
per se. Accordingly, under membrane-saturating conditions
obtained inducing p75NTR expression with 1 μg/mL doxycycline
(Fig. 2A), both mut p75NTR and wt p75NTR were able to induce
apoptosis (SI Appendix, Fig. S9). These findings, along with those
obtained in SK-N-BE(2) cells (Fig. 4), show that NT binding
regulates the partitioning of p75NTR in and out of lipid rafts,
thereby regulating its ability to induce apoptosis.
Surface-Exposed p75NTR Mediates Growth Cone Collapse in the
Presence and Absence of proNGF. Growth cone retraction caused
by overexpression of both wt p75NTR and a C256A p75NTR
mutant was reported to occur upon proNGF administration in
developing neurons (20). Hence, p75NTR collapse action may not
necessarily depend on receptor partitioning in cholesterol-rich
regions, unlike apoptotic signaling (Fig. 5). We therefore inves-
tigated the mechanisms of axonal growth regulation by p75NTR.
We found that endogenous levels of p75NTR can also regulate axon
branching. Axonal arbors of CA3 neurons projecting into the
CA1 region are significantly more ramified and occupy larger
areas in p75NTR KO mice than in wt mice (SI Appendix, Fig. S10
A and B). This is reflected in a higher number of synaptic bou-
tons (SI Appendix, Fig. S10C), consistent with previous obser-
vations of p75NTR KO animals showing increased dendritic
complexity (50). Neuronal cultures of the same animals recapit-
ulated this result (Fig. 6 A and B), with p75NTR KO axons being
longer (Fig. 6C) and displaying an increased number of branch
points (Fig. 6D) and lateral growth cones per length unit (Fig. 6E)
with respect to wt axons. Importantly, transient expression of wt
p75NTR or mut p75NTR constructs in p75NTR KO neurons com-
pletely rescued the phenotype observed in wt neurons (Fig. 6 C–
E). In agreement with previous data (20), expression of either
wt p75NTR or mut p75NTR in hippocampal neurons leads to growth
cone collapse in response to proNGF (SI Appendix, Fig. S11 A and
B). Overall, this suggests that the regulation of axonal complexity and
proNT-dependent collapse of growth cones share a common mech-
anism regulated by p75NTR independently on Cys256 and other res-
idues mutated or missing in mut p75NTR (Fig. 2C).
To gain further insight into this mechanism, we monitored the
membrane pool of S6-p75NTR–EGFP during collapse by bio-
tinylating the receptors on the cell surface before proNGF in-
cubation, and detecting receptors still present on the plasma
membrane with streptavidin-Qdot after proNGF incubation for
30 min; EGFP fluorescence marked the total content of p75NTR
(Fig. 7A). The proNGF caused a dramatic increase in the mem-
brane pool of both wt p75NTR and mut p75NTR, while lower levels
of membrane p75NTR were detected in untreated neurons (Fig. 7
B and C). Inhibition of dynamin-dependent internalization with
Dynasore (Fig. 7D), to maintain wt and mut S6-p75NTR–EGFP on
the surface regardless of proNGF administration (Fig. 7E), was
sufficient to drive the growth cone collapse, independently from
ligands; indeed, proNGF had no further collapse-inducing effect,
implying that p75NTR exposure is a downstream event to ligand
binding (Fig. 7F and SI Appendix, Fig. S11A). Notably, Dynasore
alone in untransfected neurons did not have such a prominent
effect, although a trend could be observed upon drug treatment
and proNGF administration (Fig. 7F); this is likely due to a
fraction of hippocampal neurons expressing detectable levels
of p75NTR, as previously shown (29). Inhibiting p75NTR in-
ternalization by expressing the K44A dominant negative form of
dynamin had the same effect (SI Appendix, Fig. S11 D and E),
confirming the results obtained with Dynasore. Furthermore, we
found that the mechanism responsible for the removal of p75NTR from
the plasma membrane in the absence of proNGF is dependent on
clathrin, as blocking clathrin-dependent endocytosis by Pitstop2 was
sufficient to accumulate surface p75NTR and trigger neuronal growth
cone collapse (Fig. 7 G–J).
These data suggest that p75NTR has an intrinsic collapsing
activity when retained on the growth cone membrane, and in-
ternalization inhibition is a sufficient driving force that does not
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necessarily require NT-induced partitioning into raft domains.
Indeed, both wt p75NTR and mut p75NTR constructs similarly
regulate axonal complexity. Overexpression has been called into
question in the evaluation of growth cone collapse (18). Indeed,
p75NTR expression by a constitutively strong promoter results in
a many-fold expression increase compared with that of p75NTR
induced at 0.05 μg/mL doxycycline (SI Appendix, Fig. S12), which
recapitulates the behavior of endogenous p75NTR (Fig. 5). We
therefore evaluated the effect of proNGF on neurons infected with
wt p75NTR or mut p75NTR and induced with 0.05 μg/mL or 1 μg/mL
doxycycline (SI Appendix, Fig. S13A). We found that growth cone
collapse could still be observed, although at lower levels than
with overexpressed p75NTR. The growth cone area decreases with
increasing surface p75NTR density: In particular, a threshold for
growth cone collapse was found in the range of 1 to 2 receptors per
square micrometer (SI Appendix, Fig. S13 B and C). Although
slightly higher than the receptor ranges explored in our advanced
imaging (Fig. 3 and SI Appendix, Fig. S7) and apoptosis assays (Fig.
A B
C D E F
G
doxycycline
Fig. 5. Membrane cholesterol regulates proBDNF apoptotic signaling via p75NTR. Experimental timeline (A) and quantification of cholesterol (intensity of filipin III
staining) in cortical neurons treated with mevastatin/MβCD (meva.) or soluble cholesterol (chol.), relative to untreated neurons (B). ***P < 0.001, 1-way ANOVA
(Tukey’s multiple comparisons). Box-plots represent 25th to 75th percentiles, whiskers indicate Tukey intervals, and dots represent outliers. div, day in vitro. (C)
Percentage of cleaved caspase-3–positive neurons in wt cortical neurons (naive, white columns) or in the same neurons treated with mevastatin (green columns) or
cholesterol load (red columns) in the absence or presence of proBDNF. (D) Percentage of cleaved caspase-3–positive neurons in untransduced p75NTR KO cortical
neurons (untr [untransduced], white columns) or in the same neurons transduced with wt p75NTR (gray columns) or mut p75NTR (black columns) and induced with
0.05 μg/mL doxycycline, with or without proBDNF. White and gray columns are reported from Fig. 1F. The same is shown in conditions of cholesterol depletion (E,
mevastatin) and cholesterol load (F, cholesterol) of the neurons. For C–F, **P < 0.01 and ***P < 0.001, 1-way ANOVA test (with Tukey’s comparison of means). ns,
not significant at the 0.05 level. Bars are mean ± SEM, and superimposed dots represent samples. (G) Representative confocal images of neurons expressing wt
p75NTR or mut p75NTR, untreated or treated with proBDNF. Naive neurons (Top), cholesterol-enriched (cholesterol) neurons (Middle), and cholesterol-depleted
(mevastatin) neurons (Bottom) are shown. MAP2 (green) and cleaved caspase-3 (red) are indicated. (Scale bars, 20 μm.)
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5), this value seems compatible with physiological levels observed at
least in a subset of central neurons displaying sufficient p75NTR
levels to drive cone retraction (29). At 0.05 μg/mL doxycycline,
p75NTR explores a range of expression levels on the neuronal sur-
face, with densities spanning from below to above the range of 1 to
2 receptors per square micrometer, and this explains why only a
subpopulation of neurons undergoes growth cone collapse in this
sample (SI Appendix, Fig. S13). Importantly, the growth cone area
distribution for mut p75NTR neurons was not significantly different
from that for wt p75NTR, and the 2 forms displayed similar area
versus p75NTR level dependency (SI Appendix, Fig. S13C), thus
ruling out overexpression as the cause for their identical behavior
(Fig. 6). This demonstrates that growth cone collapse via p75NTR
can occur at receptor levels close to or slightly higher than the
natural average density in neurons, and that both p75NTR forms are
equally capable of mediating it.
Discussion
To solve the oligomerization conundrum of p75NTR in a live cell
context and to gain insight into its mechanisms of activation by
NTs, we applied a single-molecule fluorescence approach that
we had already validated to image and track NT receptors and
their ligands (21–25). This avoids the use of indirect methods like
labeled antibodies or ligands and obviates the problem of Qdot
steric hindrance (51) (SI Appendix, Fig. S3). In neuroblastoma
cells (Movie S1 and Figs. 2D and 4A), as well as in primary
neurons (Fig. 4B, SI Appendix, Fig. S7, and Movie S2), p75NTR
exhibits fast dynamics and is mostly present in monomeric form.
NT or proNT stimulations do not alter its stoichiometry signifi-
cantly (Figs. 3 and 4A); instead, our data show that p75NTR
molecules only form transient homointeractions if any (Figs. 2
E–G and 3), indicating that dynamic interactions are likely to
underlie receptor activation.
The existence of preformed p75NTR oligomers in the mem-
brane has been hotly debated, with different groups reporting
p75NTR dimers (1, 17), trimers (13), or a mixture of both (16, 20).
Evidence for oligomerization mostly came from the electro-
phoretic shift of the immunodetected receptor band of 2- or 3-
fold the weight of the monomer, in nonreducing conditions or
after chemical cross-linking. However, this constitutes an indirect
way of investigating stoichiometry. Indeed, both run length and
intensity of higher weight bands in a gel critically depend on
several technical parameters, such as lysis conditions, antibody,
or composition of the gel (SI Appendix, Table S1 and compare,
e.g., SI Appendix, Figs. S4 and S14). Heavier p75NTR-immuno-
reactive bands may be the result of p75NTR homo- or hetero-
aggregation with unknown proteins or lipids in close proximity.
Indeed, p75NTR association with gangliosides in response to li-
gands was already reported (52). Thus, the shifted bands could
simply reflect crowding of molecules interacting transiently in
cholesterol-rich regions, which are stabilized by certain lysis
conditions, rather than a stable physical association. This is
supported by the recent observation that the putative oligomeric
shifted band of another TNF receptor, Death Receptor 5, is
impaired by cholesterol-depletion treatments (53). Here, we
provide a direct and quantitative estimate of the human full-
length p75NTR oligomerization state in the cell membrane. Our
data on dynamics and bleaching steps demonstrate a pre-
dominant monomeric p75NTR form (∼77%; Fig. 3B). Notably,
this percentage is almost identical (Fig. 3B), as is the diffusive
profile (Fig. 2 D–G), to a reference monomeric p75NTR construct
(mut p75NTR), which bears all mutations impairing p75NTR gel-
shifted bands (17, 20, 33) (Fig. 2C). Therefore, even if ∼22% of
p75NTR apparent dimers are detected, they are not dependent on
the mutated or deleted residues; this fraction likely constitutes
an overestimation due to nonresolved pairs of individual
monomers merely in proximity, especially in small zones on the
membrane where diffusivity is hindered; a similar effect could
also explain the presence of trimers and tetramers for dim
p75NTR. For G protein-coupled receptors, apparent oligomers
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Fig. 6. wt p75NTR and mut p75NTR mediate growth cone collapse and regulate axon complexity. (A) Hippocampal neurons from wt (Left) and p75NTR KO
(Right) mice. Axons from EGFP- and TagRFP-actin–expressing neurons are drawn in black and superimposed to the EGFP channel (grayscale). (Scale bar,
100 μm.) (B) Magnification of axon terminals from images in A also showing immunofluorescence for the axonal marker NF-200. TagRFP-actin accumulates at
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were quantified to be a 3/6-fold overestimation in similar ranges
of receptor densities (54).
Our dynamics data question the possibility of a covalent TM
p75NTR dimerization, challenging a previous model for the
p75NTR mechanism of action, which postulates that NT binding
to the putative preformed p75NTR covalent dimer induces a
conformational change propagated via Cys256, leading to sepa-
ration of death domains (17). This model was already challenged
by structural considerations on the flexibility of the JM and
chopper domains (19). We propose an alternative molecular
basis for receptor activation, in which p75NTR monomers pref-
erentially concentrate into signaling-competent membrane
microdomains, like lipid rafts, upon NGF stimulation, with
C256 and G265 residues playing a crucial role in this compart-
mentalization (Fig. 8A). Indeed, the importance of Cys256 was
corroborated by the failure of proBDNF-induced neuronal ap-
optosis in mut p75NTR knock-in mice (18). This is supported
by the observation that wt (but not mut) p75NTR displays higher
average residency in GM-1–rich regions upon NGF binding (Fig. 4
E and F), and that the diffusion of NGF-bound wt p75NTR and mut
p75NTR displays different responses to cholesterol-modulation
treatments (Fig. 4D).
Robust evidence correlates NT signaling, especially proa-
poptotic signaling, to the residency of NT receptors in lipid rafts,
probably because many interactors and effectors of the pathway
are commonly associated with these regions (42, 44, 55). Indeed,
p75NTR palmitoylation (Fig. 1C) can mediate the association of
the protein with lipid rafts (1), and is necessary for p75NTR
proapoptotic activity (27). Hence, p75NTR may be capable of
activating apoptosis in these zones only, and lack of proBDNF-
induced apoptosis by mut p75NTR (Fig. 5D) can be explained by
its inability to enter these regions upon NT binding (Fig. 8A).
Our diffusivity data with cholesterol modulation also point to
this interpretation (Fig. 4 C–F). It is unclear to us why the
modifications of TM residues may impair the residency of
p75NTR in lipid rafts. Available models (38) and NMR structures
(56) of the p75NTR TM domain agree in not mapping the 2 res-
idues on the same side of the TM helix. We speculate that these
residues are involved in creating peculiar interfaces that bind
specific lipids (possibly cholesterol itself) or proteic components
of lipid rafts; in support of this, cholesterol depletion impaired
proBDNF-induced apoptosis (Fig. 5E).
Despite their difference in apoptotic signaling, wt p75NTR and
mut p75NTR are equally capable of mediating growth cone
collapse in developing neurons (20) (SI Appendix, Fig. S11 A and
B). Here, we showed that this effect is linked to the local con-
centration of the receptor on the growth cone surface. Although
it was previously evaluated in p75NTR overexpression regimes
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(20, 29), we show here that it is still observed when p75NTR is ∼4-
to 20-fold less expressed (SI Appendix, Fig. S12), thus falling in a
range of concentrations compatible with the endogenous levels
(SI Appendix, Fig. S13). This is particularly plausible if the ob-
served polarized distribution of surface p75NTR is taken into
account (Fig. 1D). The mechanism is likely to support collapse in
a cone-autonomous way. Indeed, collapsed cones show higher
levels of surface p75NTR than extended ones even within the
same neuron (Fig. 7J). The p75NTR surface density is most
probably controlled by removal from the plasma membrane and
sequestration in intracellular stores. Acute proNGF administra-
tion increases both wt p75NTR and mut p75NTR surface pools at
growth cones, and inhibition of p75NTR internalization mimics
the proNT effect (Fig. 7 and SI Appendix, Fig. S11). Although we
cannot tell whether proNGF prevents p75NTR internalization or
increases p75NTR recycling onto the plasma membrane (Fig. 8B),
we argue that a signaling cascade activated by surface-exposed
p75NTR is responsible for growth cone retraction and axonal
complexity. This mechanism could be activated by proNT binding,
p75NTR local accumulation (28), or interactions with membrane
partners like ephrin-A (57), eventually leading to Rac and RhoA
activation (29, 58). It is also possible that p75NTR binds different
proteins on the plasma membrane and intracellular stores, possibly
regulating their availability. In any case, this activity is not de-
pendent on the TM and JM residues mutated or missing in mut
p75NTR, and therefore on the membrane partitioning necessary for
proapoptotic signaling (Fig. 8). Accordingly, axonal extension and
branching are enhanced in p75NTR KO hippocampal neurons (Fig.
6 A and B and SI Appendix, Fig. S10) and this enhancement is
suppressed by either wt p75NTR or mut p75NTR expression (Fig. 6
C–E). These data corroborate the observation that sympathetic
sprouting is enhanced in p75NTR-exIII and p75NTR-exIV KO mice
(59). In addition, p75NTR-exIII and p75NTR-exIV KO neurons display
increased dendritic complexity, and p75NTR-rich dendritic regions
are particularly devoid of collateral branches (50).
In summary, our results demonstrate that p75NTR exists pre-
dominantly as a fast-diffusing monomer at the neuronal plasma
membrane, and that its signaling capabilities depend on the
membrane microdomains traversed and on the amount of
surface-exposed receptor available in particular neuronal com-
partments. Interestingly, while this paper was in preparation, the
existence of TrkB dimers was challenged by demonstrating that
this receptor is mostly active as monomer on the plasma mem-
brane: This posed severe doubts regarding a long-accepted view
of TrkB dimerization as a key step in the transduction of BDNF
signaling, partially supported by electrophoretic shifts after
chemical cross-linking (60). A scenario emerges in which avail-
ability of NT receptor monomers is a fundamental step for signal
transduction via Trk-NT-p75NTR constructs induced by the
binding of clustered forms of NTs, as recently proposed based on
structural data (61). It remains to be established, however,
whether coexpression of Trks results in changes of the p75NTR
oligomerization state in the cell plasma membrane. In any case,
the multifaceted mechanisms of action of the p75NTR monomer
suggested by our findings can successfully reconcile most of the
apparently conflicting data reported in the literature for the
structure and function of this pleiotropic receptor.
Material and Methods
Stoichiometry by Single-Molecule Step Photobleaching. The wt p75NTR, mut
p75NTR, and dim p75NTR constructs were transduced in SK-N-BE(2) cells, labeled
with Abberior 635P and then fixed for 90 min at room temperature with 4%
paraformaldehyde, 5% sucrose, and 0.1% glutaraldehyde in phosphate-
buffered saline (PBS); washed 5 times with PBS; and imaged in PBS on the
TIRF microscope. Three thousand-frame movies were acquired in a 32.68 ×
32.68-μm region of interest centered on the selected cells, with 21 ms of in-
tegration time. Time series were then analyzed as described previously (37).
Cleaved Caspase-3 Assay. Cortical neurons from wt p75NTR and p75NTR KO mice
seeded on coverslips were left untreated or transduced with wt/mut p75NTR.
On day in vitro 3 (DIV3), neurons were treated for 12 h with 20 ng/mL human
proBDNF. Samples were then fixed in cold 1:1 acetone/methanol solution for
15 min at −20 °C and processed for immunofluorescence with anti–cleaved
caspase-3 (1:300, 9664; Cell Signaling Technology) and anti–MAP-2 (1:2,500,
M9942; Sigma–Aldrich) antibodies. Samples were imaged on a confocal mi-
croscope with a 20× air objective (numerical aperture = 0.5) and pinhole at
1.5 airy units. Cleaved caspase-3–positive neurons were defined as MAP2-
positive cells displaying a mean intensity above an intensity threshold in the
cleaved caspase-3 channel.
Growth Cone Collapse Assay. Hippocampal neurons were transfected with S6-
p75NTR–GFP constructs; alternatively, they were transduced with inducible wt
p75NTR or mut p75NTR and induced at 0, 0.05, or 1 μg/mL doxycycline
concentrations. On DIV3, p75NTR was biotinylated at the cell surface be-
fore incubation with 20 ng/mL proNGF. Neurons were then washed once
and incubated with 10 nM streptavidin-Qdot655, washed 5 times, and
fixed in 2% formaldehyde and 5% sucrose in PBS before confocal or TIRF
imaging. To inhibit p75NTR endocytosis, the above experiment was repeated
in the presence of 80 μM Dynasore (Sigma–Aldrich) or 25 μM Pitstop2
(Abcam). We measured 1) the area of all detectable growth cones; 2) for S6-
p75NTR–EGFP constructs, the ratio between the Qdot and EGFP channels as a
actin remodelling
growth cone collapse
proapoptotic signal
proNT?
proNT
mature NT
Dynasore, Pitstop
out
in
B
A
cholesterol rich
Fig. 8. Proposed model for p75NTR signaling on the plasma membrane. (A)
Model of the membrane partitioning undergone by wt p75NTR (Left, green)
or mut p75NTR (Right, green) upon NGF (orange) binding. Cholesterol-rich,
signaling-competent regions are represented with increased membrane
thickness and containing cholesterol and gangliosides. Partitioning is high-
lighted by the arrows in opposite directions. (B) Model of p75NTR signaling at
the membrane and downstream internalization. Signaling can occur from
cholesterol-poor or cholesterol-rich membrane regions, resulting in receptor
internalization within clathrin-positive (green) or caveolin-positive (red)
endosomes. In our model, interactors of surface-retained p75NTR (magenta),
involved in actin remodeling and growth cone collapse, are more abundant
in nonraft regions as this pathway is not impaired by the mutations in-
troduced in mut p75NTR. Conversely, apoptotic signaling effectors (light and
dark blue) are enriched in raft platforms being efficiently activated only by NGF-
bound wt p75NTR. Different from mature NTs, proNTs at the growth cones cause
surface accumulation of p75NTR, which could arise from internalization inhibition
(as for Dynasore and Pitstop2 treatments or expression of the dominant negative
K44A dynamin) or by increased receptor recycling at the membrane.
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measure of membrane versus total receptor pool; and 3) for all p75NTR
constructs, the intensities in the Qdot channel as a measure of membrane
abundance at the different expression levels.
More details on material and methods appear in SI Appendix. Readers will
be able to access codes and materials by directly contacting the corre-
sponding authors.
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